Initializing terminal quote pipeline...

Command Palette

Search for a command to run...

EC

Eckem Holdings Berhad

ECKEM0463MITIListed

M & A Securities Sdn Bhd · ACE Market · Listing 03 Jul 2026

Open
25 May 2026
Close
19 Jun 2026
Ballot
24 Jun 2026
Allot
01 Jul 2026
List
03 Jul 2026

Auto Summary

IPO Price
RM0.12
Shares After IPO
625.00 M
Market Cap
RM75,000,000
Revenue
RM38,662,000
PAT
RM4,478,000
Revenue CAGR
2.0%
PAT CAGR
-19.2%
EPS
0.72 sen
IPO PER
16.8x
NA/share
RM0.08
P/B
1.50x
ROE
11.5%
Gearing
0.98x
Current Ratio
3.25x
Growth Score
4.3/10
Risk Score
5.8/10

Revenue

37.15 M
2023
43.93 M
2024
38.66 M
2025

PAT

6.86 M
2023
5.65 M
2024
4.48 M
2025

Margins & Gearing

GP Margin
202332.4%
202427.5%
202527.8%
PAT Margin
202318.5%
202412.8%
202511.6%
Gearing
20230.70x
20241.01x
20250.98x

Utilisation Of Proceeds

Construction of new corporate office, warehouse and laboratory40.0%
Expansion of new production line for our rubber products13.3%
Repayment of bank borrowings9.7%
Working capital11.7%
Estimated listing expenses25.3%
Growth Allocation
53.3%
Listing Expense Flag
25.3%

Valuation Breakdown

Conservative
RM0.11
15x PER · -10.4%
Base
RM0.13
18x PER · +7.5%
Bull
RM0.14
20x PER · +19.4%
IPORM0.12
ConservativeRM0.11
BaseRM0.13
BullRM0.14
CurrentRM0.12

Category Scores

6.1
Financial Strength7.3/10
Profitability6/10
Growth Prospect4.3/10
Balance Sheet7.5/10
Valuation7/10
Risk5.8/10

Growth Vs Risk Matrix

SpeculativeAttractive Growth IPOAvoidDefensive
ECKEM: Growth 4.3/10 · Risk 5.8/10

Growth increases upward and risk decreases to the right, so the most attractive IPOs sit in the top-right quadrant.

Listing Gain
neutral
1-3 Year Hold
hold
Conclusion

Eckem comes to market on a deteriorating trend. Revenue fell 12.0% in FYE2025 to RM38.7m, below where it stood in FYE2022, and PAT has declined for two consecutive years to RM4.5m as gross margin slipped from 32.4% to 27.8%. Earnings quality is the weakest part of the case: this is a distribution business being squeezed between input costs and contracted selling prices. Growth is negative on both revenue and profit over the stored window, so the equity story depends wholly on what the proceeds build. On that count the raise is credible - 53.3% funds a consolidated office, warehouse and laboratory plus a new rubber production line - but the payoff sits 24 to 36 months out. The balance sheet is mixed: liquidity is comfortable at 3.25x, yet 0.98x gearing is the highest in the batch and only RM1.45m of proceeds reduces it. At about 17x trailing earnings the multiple is being paid on the lowest profit in four years, which is a demanding entry point, and non-Shariah status thins the institutional bid. Principal risk is that margin compression continues through the build-out period.

Strengths

- Broad portfolio of 310 specialty chemical products across coatings, personal care and automotive end markets. - Current ratio strengthened from 2.03x to 3.25x over the review period. - Cash and bank balances grew every year, reaching RM8.2m in FYE2025. - 53.3% of proceeds fund new premises and a new rubber production line.

Weaknesses

- PAT fell for two consecutive years, from RM6.86m to RM4.48m. - Revenue declined 12.0% in FYE2025 to RM38.7m, below the FYE2022 level. - Gross margin dropped from 32.4% to 27.8% and has not recovered. - Gearing of 0.98x is the highest in the batch. - Listing expenses absorb 25.33% of gross proceeds.

Opportunities

- Consolidating operations into purpose-built premises should reduce the cost of running three separate sites. - The new rubber production line diversifies away from pure chemical distribution into manufacturing. - Customer concentration in Kuala Lumpur and Selangor suits the planned central-region facility.

Threats

- Specialty chemical distribution margins compress when upstream resin and pigment prices move against contracted selling prices. - Downstream coatings and automotive demand tracks the domestic construction and vehicle cycles. - Non-Shariah classification limits access to a large part of the Malaysian institutional bid.

IPO Balloting Calculator

Tier snapping, subscription cost, and expected-value estimate.

Recommended Units
100,100
Cost
RM12,012
Success Rate
18.54%
Open EV
RM445
Mid EV
RM1,114
UnitsTierCostSuccessOpen ProfitOpen EVHold ProfitHold EV
1001RM1212.36%RM2RM0RM6RM1
3002RM3612.98%RM7RM1RM18RM2
1,1003RM13213.60%RM26RM4RM66RM9
2,1004RM25214.22%RM50RM7RM126RM18
3,1005RM37214.83%RM74RM11RM186RM28
4,1006RM49215.45%RM98RM15RM246RM38
6,1007RM73216.07%RM146RM24RM366RM59
11,1008RM1,33216.69%RM266RM44RM666RM111
20,1009RM2,41217.31%RM482RM83RM1,206RM209
50,10010RM6,01217.92%RM1,202RM216RM3,006RM539
100,10011RM12,01218.54%RM2,402RM445RM6,006RM1,114
200,10012RM24,01219.16%RM4,802RM920RM12,006RM2,300
500,10013RM60,01219.78%RM12,002RM2,374RM30,006RM5,934
1,000,10014RM120,01220.40%RM24,002RM4,895RM60,006RM12,239
2,000,10015RM240,01221.01%RM48,002RM10,087RM120,006RM25,218
5,000,10016RM600,01221.63%RM120,002RM25,958RM300,006RM64,896
10,000,10017RM1,200,01222.25%RM240,002RM53,400RM600,006RM133,499

The trailing 100 units are intentional: applying just over a boundary, such as 20,100 instead of 20,000, lands in the next balloting tier. Success rate is a heuristic, not published balloting odds.

IPO Autopsy is for educational and research purposes only and is not investment advice, a recommendation, or an offer to subscribe for securities.